Over the last 7 days, the Clinical Research and Equipment industry has risen 1.4%, driven by gains from Bio-Techne of 23%. During this same period, the Illumina underperformed, falling 8.3%. In the last 12 months, the industry was up 4.9%. Earnings are forecast to grow by 17% annually.
Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 08 May 2024 | US$715.6b | US$141.6b | US$12.5b | 39.8x | 57.4x | 5.1x |
Fri, 05 Apr 2024 | US$727.9b | US$142.1b | US$12.8b | 42.7x | 56.9x | 5.1x |
Sun, 03 Mar 2024 | US$744.0b | US$142.2b | US$12.8b | 44.2x | 58.1x | 5.2x |
Tue, 30 Jan 2024 | US$698.4b | US$153.8b | US$14.2b | 36x | 49.3x | 4.5x |
Thu, 28 Dec 2023 | US$704.7b | US$153.8b | US$14.2b | 37.9x | 49.5x | 4.6x |
Sat, 25 Nov 2023 | US$642.8b | US$153.8b | US$14.0b | 34.7x | 45.9x | 4.2x |
Mon, 23 Oct 2023 | US$607.7b | US$154.6b | US$11.2b | 31.3x | 54.2x | 3.9x |
Wed, 20 Sep 2023 | US$688.0b | US$154.6b | US$11.2b | 32.3x | 61.4x | 4.5x |
Fri, 18 Aug 2023 | US$708.0b | US$154.6b | US$11.2b | 32.5x | 63.2x | 4.6x |
Sun, 16 Jul 2023 | US$706.2b | US$155.5b | US$12.7b | 29.3x | 55.7x | 4.5x |
Tue, 13 Jun 2023 | US$692.4b | US$152.4b | US$12.5b | 29.3x | 55.4x | 4.5x |
Thu, 11 May 2023 | US$685.9b | US$152.3b | US$12.7b | 30x | 53.9x | 4.5x |
Sat, 08 Apr 2023 | US$720.1b | US$154.6b | US$10.8b | 26.7x | 66.7x | 4.7x |
Mon, 06 Mar 2023 | US$739.7b | US$154.5b | US$10.9b | 31x | 68x | 4.8x |
Wed, 01 Feb 2023 | US$755.3b | US$155.5b | US$9.0b | 30.7x | 84x | 4.9x |
Fri, 30 Dec 2022 | US$761.4b | US$155.2b | US$8.8b | 29.4x | 86.8x | 4.9x |
Sun, 27 Nov 2022 | US$767.3b | US$155.1b | US$8.8b | 28.6x | 87.3x | 4.9x |
Tue, 25 Oct 2022 | US$691.5b | US$152.9b | US$17.4b | 24.8x | 39.6x | 4.5x |
Thu, 22 Sep 2022 | US$727.7b | US$152.2b | US$17.3b | 26.4x | 42x | 4.8x |
Sat, 20 Aug 2022 | US$817.8b | US$152.3b | US$17.3b | 31.1x | 47.2x | 5.4x |
Mon, 18 Jul 2022 | US$747.8b | US$148.1b | US$20.1b | 30.8x | 37.2x | 5.1x |
Wed, 15 Jun 2022 | US$683.7b | US$148.1b | US$20.1b | 28x | 34x | 4.6x |
Fri, 13 May 2022 | US$689.9b | US$147.7b | US$20.0b | 28.9x | 34.4x | 4.7x |
Sun, 10 Apr 2022 | US$896.9b | US$146.5b | US$25.3b | 37.3x | 35.4x | 6.1x |
Tue, 08 Mar 2022 | US$833.0b | US$146.2b | US$25.3b | 34.5x | 33x | 5.7x |
Thu, 03 Feb 2022 | US$878.9b | US$139.4b | US$27.7b | 38.9x | 31.8x | 6.3x |
Sat, 01 Jan 2022 | US$999.2b | US$138.0b | US$27.3b | 44.9x | 36.6x | 7.2x |
Mon, 29 Nov 2021 | US$967.8b | US$138.0b | US$27.3b | 42.4x | 35.5x | 7x |
Wed, 27 Oct 2021 | US$747.4b | US$106.6b | US$18.7b | 48.1x | 39.9x | 7x |
Fri, 24 Sep 2021 | US$763.8b | US$105.9b | US$18.6b | 53x | 41x | 7.2x |
Sun, 22 Aug 2021 | US$719.8b | US$105.8b | US$18.7b | 50.6x | 38.6x | 6.8x |
Fri, 09 Jul 2021 | US$656.3b | US$101.0b | US$17.6b | 39.3x | 37.2x | 6.5x |
34.4x
How does U.S. Clinical Research and Equipment compare with similar industries?
US Market | 3.31% | |
Healthcare | 1.83% | |
Life Sciences | 1.36% | |
Clinical Research and Equipment | 1.36% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TECH Bio-Techne | US$77.46 | 22.5% +US$2.2b | -4.5% | PE60x | |
TMO Thermo Fisher Scientific | US$572.87 | 0.7% +US$1.6b | 7.1% | PE36.2x | |
DHR Danaher | US$248.76 | 0.9% +US$1.6b | 5.8% | PE45.3x | |
ICLR ICON | US$314.54 | 5.6% +US$1.4b | 68.1% | PE38.1x | |
A Agilent Technologies | US$141.27 | 3.1% +US$1.2b | 10.9% | PE33.5x |